Market Research Logo

A Product and Pipeline Analysis of the Global Immunoglobulin Market

2015 North American Category Management Report—Engine Control Units

Market Potential

Immunoglobulin (Ig) therapies are life-saving medicines. They have been in use for more than 60 years and provide the patient with a variety of antibodies that have proven to be beneficial for many. Often they are used as a last line of defense in many severe inflammatory diseases, and in some conditions, they are life-saving.

However, immunoglobulin G (IgG) is an expensive therapy. In the United States, the cost per treatment varies from a few hundred dollars to thousands of dollars, depending on the individual's weight, dose requirements, and brand of IgG selected. In the United States, most health plans cover the cost of IgG.

outpatient center. It can also be given in a physician's office or at a patient’s home.

About􂀀% of IgG is used as an immunosuppressive treatment of a number of autoimmune disorders, with particularly large volumes consumed by neuropathies such as chronic inflammatory demyelinating polyneuropathy (CIDP).

Globally, demand for immunoglobulin is continuously growing and the market is expected to foresee increased competition in the subcutaneous Ig segment.


  • Executive Summary
    • Key Findings
    • Major Milestones
    • Scope of the Study
  • Introduction to the Immunoglobulin Market
    • Immunoglobulin Overview
    • Classification of Immunoglobulins
    • Treatment Guidelines
    • Market Overview
      • Table Total IgG Market: Demand Volume Forecast, Global, 2013-2020*
  • Immunoglobulin Market-Marketed and Pipeline Products
    • Overview of Drugs
      • Table Total Immunoglobulin Market: Communicable Diseases Competitive Overview, Global, 2014
      • Table Total Immunoglobulin Market: Non-Communicable Diseases Competitive Overview, Global, 2014
    • Competitive Landscape-Communicable Diseases Treatments
    • Competitive Landscape-Non-Communicable Diseases Treatments
  • Communicable Diseases Product Analysis
    • Communicable Diseases Product Overview
    • Marketed Product Analysis
      • Table Total Immunoglobulin Drug Market: Communicable Diseases Marketed Product Analysis, Global, 2014
    • Pipeline Product Analysis
      • Table Total Immunoglobulin Drug Market: Communicable Diseases Pipeline Product Analysis, Global, 2014
  • Non-Communicable Diseases Product Analysis
    • Non-Communicable Diseases Product Overview
    • Marketed Product Analysis
      • Table Total Immunoglobulin Drug Market: Non-Communicable Diseases Marketed Product Analysis, Global, 2014
    • Pipeline Product Analysis
      • Table Total Immunoglobulin Drug Market: Non-Communicable iseases Marketed Product Analysis, Global, 2014
  • Immunoglobulin Market-Product Dashboards
    • Hizentra-CSL Behring
    • Civacir-Biotest
    • Flebogamma 10%-Grifols
    • GAMUNEX-C-Grifols
    • Privigen-CSL Behring
    • VariZIG-Cangene
    • Hepabulin IV-SK Holdings
    • Zutectra-Biotest
    • HyperTET-Grifols
  • Key Companies in the Immunoglobulin Market
    • Baxter International Inc.
    • Biotest AG
    • China Biologics Products, Inc.
    • CSL Behring Limited
    • Grifols
    • Octapharma AG
    • Kedrion Biopharma
  • Immunoglobulin Market-Timeline of Key Events
    • Estimated Key Product Launch Timeline
    • Approval Dates
  • Future of the Immunoglobulin Market
    • Conclusions-Future of Immunoglobulin Market

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report